Summary

According to this study, the global Targeted Protein Degradation Therapy market size will reach US$ 367 million by 2031.
Targeted Protein Degradation (TPD) therapy is an innovative approach in drug development that harnesses the cell’s natural protein disposal system to eliminate disease-causing proteins rather than simply inhibiting their activity. This strategy uses small molecules, such as PROTACs (Proteolysis Targeting Chimeras), to tag specific proteins for degradation by the ubiquitin-proteasome system. TPD offers a novel way to address previously “undruggable” targets and can provide more sustained therapeutic effects with potentially lower doses. It is being actively explored for the treatment of cancer, neurodegenerative disorders, and autoimmune diseases, with several candidates in clinical trials.
United States market for Targeted Protein Degradation Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Targeted Protein Degradation Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Targeted Protein Degradation Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Targeted Protein Degradation Therapy players cover Arvinas, Kymera Therapeutics, Dialectic Therapeutics, Bristol-Myers Squibb, Nurix, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Targeted Protein Degradation Therapy Industry Forecast” looks at past sales and reviews total world Targeted Protein Degradation Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Protein Degradation Therapy sales for 2025 through 2031. With Targeted Protein Degradation Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Protein Degradation Therapy industry.
This Insight Report provides a comprehensive analysis of the global Targeted Protein Degradation Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Protein Degradation Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Protein Degradation Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Protein Degradation Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Protein Degradation Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Protein Degradation Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Molecular Glues (CELMoDTM Agents)
Ligand-directed Degraders (LDDs)
Antibody Drug Conjugate (ADC) Degraders
Segmentation by Application:
Prostate Cancer
Breast Cancer
Lymphoma
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Arvinas
Kymera Therapeutics
Dialectic Therapeutics
Bristol-Myers Squibb
Nurix
Cullgen
C4 Therapeutics
Foghorn
Novartis
Pfizer
MSD
Origami Therapeutics
NEOsphere Biotechnologies
Dunad Therapeutics
Entact Bio
Proxygen
Monte Rosa Therapeutics
Treeline Biosciences
Ubiquigent
Kangpu Biopharmaceuticals
Ranok Therapeutics
Accutar Biotech
BeiGene
Hinova Pharma
Haisco Pharmaceutical
CTTQ

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted Protein Degradation Therapy Market Size (2020-2031)
2.1.2 Targeted Protein Degradation Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Targeted Protein Degradation Therapy by Country/Region (2020, 2024 & 2031)
2.2 Targeted Protein Degradation Therapy Segment by Type
2.2.1 Molecular Glues (CELMoDTM Agents)
2.2.2 Ligand-directed Degraders (LDDs)
2.2.3 Antibody Drug Conjugate (ADC) Degraders
2.3 Targeted Protein Degradation Therapy Market Size by Type
2.3.1 Targeted Protein Degradation Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Targeted Protein Degradation Therapy Market Size Market Share by Type (2020-2025)
2.4 Targeted Protein Degradation Therapy Segment by Application
2.4.1 Prostate Cancer
2.4.2 Breast Cancer
2.4.3 Lymphoma
2.4.4 Others
2.5 Targeted Protein Degradation Therapy Market Size by Application
2.5.1 Targeted Protein Degradation Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Targeted Protein Degradation Therapy Market Size Market Share by Application (2020-2025)
3 Targeted Protein Degradation Therapy Market Size by Player
3.1 Targeted Protein Degradation Therapy Market Size Market Share by Player
3.1.1 Global Targeted Protein Degradation Therapy Revenue by Player (2020-2025)
3.1.2 Global Targeted Protein Degradation Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Targeted Protein Degradation Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted Protein Degradation Therapy by Region
4.1 Targeted Protein Degradation Therapy Market Size by Region (2020-2025)
4.2 Global Targeted Protein Degradation Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Targeted Protein Degradation Therapy Market Size Growth (2020-2025)
4.4 APAC Targeted Protein Degradation Therapy Market Size Growth (2020-2025)
4.5 Europe Targeted Protein Degradation Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Targeted Protein Degradation Therapy Market Size Growth (2020-2025)
5 Americas
5.1 Americas Targeted Protein Degradation Therapy Market Size by Country (2020-2025)
5.2 Americas Targeted Protein Degradation Therapy Market Size by Type (2020-2025)
5.3 Americas Targeted Protein Degradation Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Protein Degradation Therapy Market Size by Region (2020-2025)
6.2 APAC Targeted Protein Degradation Therapy Market Size by Type (2020-2025)
6.3 APAC Targeted Protein Degradation Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted Protein Degradation Therapy Market Size by Country (2020-2025)
7.2 Europe Targeted Protein Degradation Therapy Market Size by Type (2020-2025)
7.3 Europe Targeted Protein Degradation Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted Protein Degradation Therapy by Region (2020-2025)
8.2 Middle East & Africa Targeted Protein Degradation Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Targeted Protein Degradation Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted Protein Degradation Therapy Market Forecast
10.1 Global Targeted Protein Degradation Therapy Forecast by Region (2026-2031)
10.1.1 Global Targeted Protein Degradation Therapy Forecast by Region (2026-2031)
10.1.2 Americas Targeted Protein Degradation Therapy Forecast
10.1.3 APAC Targeted Protein Degradation Therapy Forecast
10.1.4 Europe Targeted Protein Degradation Therapy Forecast
10.1.5 Middle East & Africa Targeted Protein Degradation Therapy Forecast
10.2 Americas Targeted Protein Degradation Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Targeted Protein Degradation Therapy Forecast
10.2.2 Canada Market Targeted Protein Degradation Therapy Forecast
10.2.3 Mexico Market Targeted Protein Degradation Therapy Forecast
10.2.4 Brazil Market Targeted Protein Degradation Therapy Forecast
10.3 APAC Targeted Protein Degradation Therapy Forecast by Region (2026-2031)
10.3.1 China Targeted Protein Degradation Therapy Market Forecast
10.3.2 Japan Market Targeted Protein Degradation Therapy Forecast
10.3.3 Korea Market Targeted Protein Degradation Therapy Forecast
10.3.4 Southeast Asia Market Targeted Protein Degradation Therapy Forecast
10.3.5 India Market Targeted Protein Degradation Therapy Forecast
10.3.6 Australia Market Targeted Protein Degradation Therapy Forecast
10.4 Europe Targeted Protein Degradation Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Targeted Protein Degradation Therapy Forecast
10.4.2 France Market Targeted Protein Degradation Therapy Forecast
10.4.3 UK Market Targeted Protein Degradation Therapy Forecast
10.4.4 Italy Market Targeted Protein Degradation Therapy Forecast
10.4.5 Russia Market Targeted Protein Degradation Therapy Forecast
10.5 Middle East & Africa Targeted Protein Degradation Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Targeted Protein Degradation Therapy Forecast
10.5.2 South Africa Market Targeted Protein Degradation Therapy Forecast
10.5.3 Israel Market Targeted Protein Degradation Therapy Forecast
10.5.4 Turkey Market Targeted Protein Degradation Therapy Forecast
10.6 Global Targeted Protein Degradation Therapy Forecast by Type (2026-2031)
10.7 Global Targeted Protein Degradation Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Targeted Protein Degradation Therapy Forecast
11 Key Players Analysis
11.1 Arvinas
11.1.1 Arvinas Company Information
11.1.2 Arvinas Targeted Protein Degradation Therapy Product Offered
11.1.3 Arvinas Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Arvinas Main Business Overview
11.1.5 Arvinas Latest Developments
11.2 Kymera Therapeutics
11.2.1 Kymera Therapeutics Company Information
11.2.2 Kymera Therapeutics Targeted Protein Degradation Therapy Product Offered
11.2.3 Kymera Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Kymera Therapeutics Main Business Overview
11.2.5 Kymera Therapeutics Latest Developments
11.3 Dialectic Therapeutics
11.3.1 Dialectic Therapeutics Company Information
11.3.2 Dialectic Therapeutics Targeted Protein Degradation Therapy Product Offered
11.3.3 Dialectic Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Dialectic Therapeutics Main Business Overview
11.3.5 Dialectic Therapeutics Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Targeted Protein Degradation Therapy Product Offered
11.4.3 Bristol-Myers Squibb Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Nurix
11.5.1 Nurix Company Information
11.5.2 Nurix Targeted Protein Degradation Therapy Product Offered
11.5.3 Nurix Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Nurix Main Business Overview
11.5.5 Nurix Latest Developments
11.6 Cullgen
11.6.1 Cullgen Company Information
11.6.2 Cullgen Targeted Protein Degradation Therapy Product Offered
11.6.3 Cullgen Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Cullgen Main Business Overview
11.6.5 Cullgen Latest Developments
11.7 C4 Therapeutics
11.7.1 C4 Therapeutics Company Information
11.7.2 C4 Therapeutics Targeted Protein Degradation Therapy Product Offered
11.7.3 C4 Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 C4 Therapeutics Main Business Overview
11.7.5 C4 Therapeutics Latest Developments
11.8 Foghorn
11.8.1 Foghorn Company Information
11.8.2 Foghorn Targeted Protein Degradation Therapy Product Offered
11.8.3 Foghorn Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Foghorn Main Business Overview
11.8.5 Foghorn Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Targeted Protein Degradation Therapy Product Offered
11.9.3 Novartis Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Targeted Protein Degradation Therapy Product Offered
11.10.3 Pfizer Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 MSD
11.11.1 MSD Company Information
11.11.2 MSD Targeted Protein Degradation Therapy Product Offered
11.11.3 MSD Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 MSD Main Business Overview
11.11.5 MSD Latest Developments
11.12 Origami Therapeutics
11.12.1 Origami Therapeutics Company Information
11.12.2 Origami Therapeutics Targeted Protein Degradation Therapy Product Offered
11.12.3 Origami Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Origami Therapeutics Main Business Overview
11.12.5 Origami Therapeutics Latest Developments
11.13 NEOsphere Biotechnologies
11.13.1 NEOsphere Biotechnologies Company Information
11.13.2 NEOsphere Biotechnologies Targeted Protein Degradation Therapy Product Offered
11.13.3 NEOsphere Biotechnologies Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 NEOsphere Biotechnologies Main Business Overview
11.13.5 NEOsphere Biotechnologies Latest Developments
11.14 Dunad Therapeutics
11.14.1 Dunad Therapeutics Company Information
11.14.2 Dunad Therapeutics Targeted Protein Degradation Therapy Product Offered
11.14.3 Dunad Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Dunad Therapeutics Main Business Overview
11.14.5 Dunad Therapeutics Latest Developments
11.15 Entact Bio
11.15.1 Entact Bio Company Information
11.15.2 Entact Bio Targeted Protein Degradation Therapy Product Offered
11.15.3 Entact Bio Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Entact Bio Main Business Overview
11.15.5 Entact Bio Latest Developments
11.16 Proxygen
11.16.1 Proxygen Company Information
11.16.2 Proxygen Targeted Protein Degradation Therapy Product Offered
11.16.3 Proxygen Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Proxygen Main Business Overview
11.16.5 Proxygen Latest Developments
11.17 Monte Rosa Therapeutics
11.17.1 Monte Rosa Therapeutics Company Information
11.17.2 Monte Rosa Therapeutics Targeted Protein Degradation Therapy Product Offered
11.17.3 Monte Rosa Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Monte Rosa Therapeutics Main Business Overview
11.17.5 Monte Rosa Therapeutics Latest Developments
11.18 Treeline Biosciences
11.18.1 Treeline Biosciences Company Information
11.18.2 Treeline Biosciences Targeted Protein Degradation Therapy Product Offered
11.18.3 Treeline Biosciences Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Treeline Biosciences Main Business Overview
11.18.5 Treeline Biosciences Latest Developments
11.19 Ubiquigent
11.19.1 Ubiquigent Company Information
11.19.2 Ubiquigent Targeted Protein Degradation Therapy Product Offered
11.19.3 Ubiquigent Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Ubiquigent Main Business Overview
11.19.5 Ubiquigent Latest Developments
11.20 Kangpu Biopharmaceuticals
11.20.1 Kangpu Biopharmaceuticals Company Information
11.20.2 Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Product Offered
11.20.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Kangpu Biopharmaceuticals Main Business Overview
11.20.5 Kangpu Biopharmaceuticals Latest Developments
11.21 Ranok Therapeutics
11.21.1 Ranok Therapeutics Company Information
11.21.2 Ranok Therapeutics Targeted Protein Degradation Therapy Product Offered
11.21.3 Ranok Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Ranok Therapeutics Main Business Overview
11.21.5 Ranok Therapeutics Latest Developments
11.22 Accutar Biotech
11.22.1 Accutar Biotech Company Information
11.22.2 Accutar Biotech Targeted Protein Degradation Therapy Product Offered
11.22.3 Accutar Biotech Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Accutar Biotech Main Business Overview
11.22.5 Accutar Biotech Latest Developments
11.23 BeiGene
11.23.1 BeiGene Company Information
11.23.2 BeiGene Targeted Protein Degradation Therapy Product Offered
11.23.3 BeiGene Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 BeiGene Main Business Overview
11.23.5 BeiGene Latest Developments
11.24 Hinova Pharma
11.24.1 Hinova Pharma Company Information
11.24.2 Hinova Pharma Targeted Protein Degradation Therapy Product Offered
11.24.3 Hinova Pharma Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Hinova Pharma Main Business Overview
11.24.5 Hinova Pharma Latest Developments
11.25 Haisco Pharmaceutical
11.25.1 Haisco Pharmaceutical Company Information
11.25.2 Haisco Pharmaceutical Targeted Protein Degradation Therapy Product Offered
11.25.3 Haisco Pharmaceutical Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Haisco Pharmaceutical Main Business Overview
11.25.5 Haisco Pharmaceutical Latest Developments
11.26 CTTQ
11.26.1 CTTQ Company Information
11.26.2 CTTQ Targeted Protein Degradation Therapy Product Offered
11.26.3 CTTQ Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 CTTQ Main Business Overview
11.26.5 CTTQ Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Targeted Protein Degradation Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Targeted Protein Degradation Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Molecular Glues (CELMoDTM Agents)
Table 4. Major Players of Ligand-directed Degraders (LDDs)
Table 5. Major Players of Antibody Drug Conjugate (ADC) Degraders
Table 6. Targeted Protein Degradation Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Targeted Protein Degradation Therapy Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Targeted Protein Degradation Therapy Market Size Market Share by Type (2020-2025)
Table 9. Targeted Protein Degradation Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Targeted Protein Degradation Therapy Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Targeted Protein Degradation Therapy Market Size Market Share by Application (2020-2025)
Table 12. Global Targeted Protein Degradation Therapy Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Targeted Protein Degradation Therapy Revenue Market Share by Player (2020-2025)
Table 14. Targeted Protein Degradation Therapy Key Players Head office and Products Offered
Table 15. Targeted Protein Degradation Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Targeted Protein Degradation Therapy Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Targeted Protein Degradation Therapy Market Size Market Share by Region (2020-2025)
Table 20. Global Targeted Protein Degradation Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Targeted Protein Degradation Therapy Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Targeted Protein Degradation Therapy Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Targeted Protein Degradation Therapy Market Size Market Share by Country (2020-2025)
Table 24. Americas Targeted Protein Degradation Therapy Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Targeted Protein Degradation Therapy Market Size Market Share by Type (2020-2025)
Table 26. Americas Targeted Protein Degradation Therapy Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Targeted Protein Degradation Therapy Market Size Market Share by Application (2020-2025)
Table 28. APAC Targeted Protein Degradation Therapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Targeted Protein Degradation Therapy Market Size Market Share by Region (2020-2025)
Table 30. APAC Targeted Protein Degradation Therapy Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Targeted Protein Degradation Therapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Targeted Protein Degradation Therapy Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Targeted Protein Degradation Therapy Market Size Market Share by Country (2020-2025)
Table 34. Europe Targeted Protein Degradation Therapy Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Targeted Protein Degradation Therapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation Therapy
Table 40. Key Market Challenges & Risks of Targeted Protein Degradation Therapy
Table 41. Key Industry Trends of Targeted Protein Degradation Therapy
Table 42. Global Targeted Protein Degradation Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Targeted Protein Degradation Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Targeted Protein Degradation Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Arvinas Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 47. Arvinas Targeted Protein Degradation Therapy Product Offered
Table 48. Arvinas Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Arvinas Main Business
Table 50. Arvinas Latest Developments
Table 51. Kymera Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 52. Kymera Therapeutics Targeted Protein Degradation Therapy Product Offered
Table 53. Kymera Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Kymera Therapeutics Main Business
Table 55. Kymera Therapeutics Latest Developments
Table 56. Dialectic Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 57. Dialectic Therapeutics Targeted Protein Degradation Therapy Product Offered
Table 58. Dialectic Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Dialectic Therapeutics Main Business
Table 60. Dialectic Therapeutics Latest Developments
Table 61. Bristol-Myers Squibb Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 62. Bristol-Myers Squibb Targeted Protein Degradation Therapy Product Offered
Table 63. Bristol-Myers Squibb Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Bristol-Myers Squibb Main Business
Table 65. Bristol-Myers Squibb Latest Developments
Table 66. Nurix Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 67. Nurix Targeted Protein Degradation Therapy Product Offered
Table 68. Nurix Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Nurix Main Business
Table 70. Nurix Latest Developments
Table 71. Cullgen Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 72. Cullgen Targeted Protein Degradation Therapy Product Offered
Table 73. Cullgen Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Cullgen Main Business
Table 75. Cullgen Latest Developments
Table 76. C4 Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 77. C4 Therapeutics Targeted Protein Degradation Therapy Product Offered
Table 78. C4 Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. C4 Therapeutics Main Business
Table 80. C4 Therapeutics Latest Developments
Table 81. Foghorn Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 82. Foghorn Targeted Protein Degradation Therapy Product Offered
Table 83. Foghorn Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Foghorn Main Business
Table 85. Foghorn Latest Developments
Table 86. Novartis Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 87. Novartis Targeted Protein Degradation Therapy Product Offered
Table 88. Novartis Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Novartis Main Business
Table 90. Novartis Latest Developments
Table 91. Pfizer Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 92. Pfizer Targeted Protein Degradation Therapy Product Offered
Table 93. Pfizer Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Pfizer Main Business
Table 95. Pfizer Latest Developments
Table 96. MSD Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 97. MSD Targeted Protein Degradation Therapy Product Offered
Table 98. MSD Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. MSD Main Business
Table 100. MSD Latest Developments
Table 101. Origami Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 102. Origami Therapeutics Targeted Protein Degradation Therapy Product Offered
Table 103. Origami Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Origami Therapeutics Main Business
Table 105. Origami Therapeutics Latest Developments
Table 106. NEOsphere Biotechnologies Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 107. NEOsphere Biotechnologies Targeted Protein Degradation Therapy Product Offered
Table 108. NEOsphere Biotechnologies Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. NEOsphere Biotechnologies Main Business
Table 110. NEOsphere Biotechnologies Latest Developments
Table 111. Dunad Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 112. Dunad Therapeutics Targeted Protein Degradation Therapy Product Offered
Table 113. Dunad Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Dunad Therapeutics Main Business
Table 115. Dunad Therapeutics Latest Developments
Table 116. Entact Bio Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 117. Entact Bio Targeted Protein Degradation Therapy Product Offered
Table 118. Entact Bio Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Entact Bio Main Business
Table 120. Entact Bio Latest Developments
Table 121. Proxygen Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 122. Proxygen Targeted Protein Degradation Therapy Product Offered
Table 123. Proxygen Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Proxygen Main Business
Table 125. Proxygen Latest Developments
Table 126. Monte Rosa Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 127. Monte Rosa Therapeutics Targeted Protein Degradation Therapy Product Offered
Table 128. Monte Rosa Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Monte Rosa Therapeutics Main Business
Table 130. Monte Rosa Therapeutics Latest Developments
Table 131. Treeline Biosciences Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 132. Treeline Biosciences Targeted Protein Degradation Therapy Product Offered
Table 133. Treeline Biosciences Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Treeline Biosciences Main Business
Table 135. Treeline Biosciences Latest Developments
Table 136. Ubiquigent Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 137. Ubiquigent Targeted Protein Degradation Therapy Product Offered
Table 138. Ubiquigent Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. Ubiquigent Main Business
Table 140. Ubiquigent Latest Developments
Table 141. Kangpu Biopharmaceuticals Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 142. Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Product Offered
Table 143. Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Kangpu Biopharmaceuticals Main Business
Table 145. Kangpu Biopharmaceuticals Latest Developments
Table 146. Ranok Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 147. Ranok Therapeutics Targeted Protein Degradation Therapy Product Offered
Table 148. Ranok Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 149. Ranok Therapeutics Main Business
Table 150. Ranok Therapeutics Latest Developments
Table 151. Accutar Biotech Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 152. Accutar Biotech Targeted Protein Degradation Therapy Product Offered
Table 153. Accutar Biotech Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 154. Accutar Biotech Main Business
Table 155. Accutar Biotech Latest Developments
Table 156. BeiGene Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 157. BeiGene Targeted Protein Degradation Therapy Product Offered
Table 158. BeiGene Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 159. BeiGene Main Business
Table 160. BeiGene Latest Developments
Table 161. Hinova Pharma Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 162. Hinova Pharma Targeted Protein Degradation Therapy Product Offered
Table 163. Hinova Pharma Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 164. Hinova Pharma Main Business
Table 165. Hinova Pharma Latest Developments
Table 166. Haisco Pharmaceutical Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 167. Haisco Pharmaceutical Targeted Protein Degradation Therapy Product Offered
Table 168. Haisco Pharmaceutical Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 169. Haisco Pharmaceutical Main Business
Table 170. Haisco Pharmaceutical Latest Developments
Table 171. CTTQ Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors
Table 172. CTTQ Targeted Protein Degradation Therapy Product Offered
Table 173. CTTQ Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 174. CTTQ Main Business
Table 175. CTTQ Latest Developments


List of Figures
Figure 1. Targeted Protein Degradation Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Protein Degradation Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Targeted Protein Degradation Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Targeted Protein Degradation Therapy Sales Market Share by Country/Region (2024)
Figure 8. Targeted Protein Degradation Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Targeted Protein Degradation Therapy Market Size Market Share by Type in 2024
Figure 10. Targeted Protein Degradation Therapy in Prostate Cancer
Figure 11. Global Targeted Protein Degradation Therapy Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 12. Targeted Protein Degradation Therapy in Breast Cancer
Figure 13. Global Targeted Protein Degradation Therapy Market: Breast Cancer (2020-2025) & ($ millions)
Figure 14. Targeted Protein Degradation Therapy in Lymphoma
Figure 15. Global Targeted Protein Degradation Therapy Market: Lymphoma (2020-2025) & ($ millions)
Figure 16. Targeted Protein Degradation Therapy in Others
Figure 17. Global Targeted Protein Degradation Therapy Market: Others (2020-2025) & ($ millions)
Figure 18. Global Targeted Protein Degradation Therapy Market Size Market Share by Application in 2024
Figure 19. Global Targeted Protein Degradation Therapy Revenue Market Share by Player in 2024
Figure 20. Global Targeted Protein Degradation Therapy Market Size Market Share by Region (2020-2025)
Figure 21. Americas Targeted Protein Degradation Therapy Market Size 2020-2025 ($ millions)
Figure 22. APAC Targeted Protein Degradation Therapy Market Size 2020-2025 ($ millions)
Figure 23. Europe Targeted Protein Degradation Therapy Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Targeted Protein Degradation Therapy Market Size 2020-2025 ($ millions)
Figure 25. Americas Targeted Protein Degradation Therapy Value Market Share by Country in 2024
Figure 26. United States Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Targeted Protein Degradation Therapy Market Size Market Share by Region in 2024
Figure 31. APAC Targeted Protein Degradation Therapy Market Size Market Share by Type (2020-2025)
Figure 32. APAC Targeted Protein Degradation Therapy Market Size Market Share by Application (2020-2025)
Figure 33. China Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. India Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Targeted Protein Degradation Therapy Market Size Market Share by Country in 2024
Figure 40. Europe Targeted Protein Degradation Therapy Market Size Market Share by Type (2020-2025)
Figure 41. Europe Targeted Protein Degradation Therapy Market Size Market Share by Application (2020-2025)
Figure 42. Germany Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. France Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Targeted Protein Degradation Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 56. APAC Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 57. Europe Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 59. United States Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 60. Canada Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 61. Mexico Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 62. Brazil Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 63. China Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 64. Japan Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 65. Korea Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 67. India Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 68. Australia Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 69. Germany Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 70. France Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 71. UK Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 72. Italy Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 73. Russia Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 74. Egypt Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 75. South Africa Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 76. Israel Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 77. Turkey Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)
Figure 78. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Targeted Protein Degradation Therapy Market Size 2026-2031 ($ millions)